Stockscreener 앱 받기
104.24
0.66%
-0.69
시장 영업 전:
103.42
-0.82
-0.79%
Boston Scientific Corp 주식(BSX)의 최신 뉴스
Are Wall Street Analysts Predicting Boston Scientific Stock Will Climb or Sink? - Nasdaq
Are Wall Street Analysts Predicting Boston Scientific Stock Will Climb Or Sink? - Barchart.com
Boston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed Brennan - ADVFN
Boston Scientific, FDA Sued Over 'Unsafe' Spinal Implant - Law360
A Changing of the Guard at Boston Scientific, Wright Medical Group and Vision-Sciences - Medical Product Outsourcing
Can Boston Scientific Corporation (NYSE:BSX) Performance Keep Up Given Its Mixed Bag Of Fundamentals? - Yahoo Finance
Beyond the Balance Sheet: What SWOT Reveals About Boston Scienti - GuruFocus
$100 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today - Benzinga
June 13th Options Now Available For Boston Scientific (BSX) - Nasdaq
BOSTON SCIENTIFIC CORP SEC 10-Q Report - TradingView
Here are the highest-paid Mass. life sciences CEOs - The Business Journals
Edwards Lifesciences Corporation (EW): Jim Cramer Says It’s a Hold — But Is Boston Scientific Now His Favorite? - Insider Monkey
Zacks Investment Ideas Feature Highlights: Boston Scientific, Meta Platforms And Microsoft - Barchart.com
Boston Scientific Announces Results for Second Quarter 2024 - Quantisnow
Indexes Take A Well-Deserved Pause; SAP, Boston Scientific, Credicorp In Focus - Investor's Business Daily
EMEA Growth & Product Launches to Support Boston Scientific Stock - MSN
The Zacks Analyst Blog Highlights Abbott Laboratories, Boston Scientific And Medtronic - Barchart.com
The Zacks Analyst Blog Highlights Walmart, Toyota Motor, Boston Scientific and Autoscope - Yahoo Finance
Boston Scientific has positive ICD, Watchman FLX, AI data - MassDevice
Top Stock Reports for Walmart, Toyota Motor & Boston Scientific - MSN
Here is Why Growth Investors Should Buy Boston Scientific (BSX) Now - Yahoo Finance
Boston Scientific CFO Dan Brennan to retire after nearly 30 years with the company - MedTech Dive
Boston Scientific reports outcomes from Farapulse and Farapoint trial - Yahoo Finance
Boston Scientific (BSX) Price Target Raised by Barclays Followin - GuruFocus
Boston Sci expects $200M tariff hit, still raises guidance - BioWorld MedTech
Boston Scientific has positive Farapulse, Farapoint data - MassDevice
Boston Scientific (BSX) Reports Positive Results for FARAPULSE S - GuruFocus
Boston Scientific (BSX) Reports Positive Results for FARAPULSE System in Atrial Fibrillation Study | BSX Stock News - GuruFocus
Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints – Company AnnouncementFT.com - Financial Times
Boston Scientific (NYSE:BSX) Announces CFO Retirement And Strong Earnings Growth - Yahoo Finance
Boston Scientific Analysts Boost Their Forecasts Following Upbeat Results - Benzinga
Global Neuroprosthetics Market Expanding Rapidly at a CAGR of ~13% by 2032 Amid Surge in Demand for Advanced Neurological Treatments | DelveInsight - GlobeNewswire Inc.
Boston Scientific's Heart Device Success Lifts 2025 Profit Forecast - Finimize
Boston Scientific (BSX) Price Target Raised to $117 by Truist An - GuruFocus
RBC Capital lifts Boston Scientific stock target to $120 - Investing.com
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Nasdaq
Boston Scientific (BSX) Price Target Raised by Baird Amid Strong Q1 Performance | BSX Stock News - GuruFocus
Boston Scientific (BSX) Target Price Boosted by RBC Capital Afte - GuruFocus
Canaccord maintains Buy rating on Boston Scientific stock - Investing.com
Raymond James Adjusts Boston Scientific (BSX) Price Target, Reaffirms Strong Buy | BSX Stock News - GuruFocus
Boston Scientific Corporation (NYSE:BSX) Q1 2025 Earnings Call Transcript - Insider Monkey
Canaccord maintains Buy rating on Boston Scientific stock By Investing.com - Investing.com UK
Boston Scientific Stock (BSX): Solid Q1 Earnings Growth - Value The Markets
Petri Dish: Boston Scientific CFO retires; Biotech undergoes 1-for-20 reverse stock split - The Business Journals
Boston Scientific Corp (BSX) Q1 2025 Earnings Call Highlights: Strong Growth and Upgraded ... - Yahoo Finance
Boston Scientific Reports Strong Q1 2025 Growth - TipRanks
Boston Scientific: Q1 Earnings Snapshot - CT Insider
Boston Scientific Reports Strong Earnings Amid Challenges - TipRanks
Data backs Boston Scientific drug-eluting stent - MassDevice
BTIG Raises Price Target for Boston Scientific (BSX) to $124 Ami - GuruFocus
BTIG Raises Price Target for Boston Scientific (BSX) to $124 Amid Strong Outlook | BSX Stock News - GuruFocus
Why Boston Scientific (BSX) Stock Is Up Today - Yahoo Finance
Hedge Fund and Insider Trading News: Bill Ackman, Robert Charles Gibbins, Dan Loeb, Elliot Management, Lindblad Expeditions Holdings Inc (LIND), Boston Scientific Corp (BSX), and More - Insider Monkey
Boston Scientific Corp (BSX) Shares Up 4.85% on Apr 23 - GuruFocus
Boston Scientific says sales could grow up to 17% this year - MassDevice
Boston Scientific (BSX) Surpasses Q1 Expectations, Raises 2025 O - GuruFocus
Boston Scientific Revises 2025 Financial Goals Following Strong Q1 Results - Finimize
0.83%
1.65%
자본화:
|
볼륨(24시간):